EPZ015866,
1616391-87-7,
GSK3203591,
GSK591,
2-(cyclobutylamino)-N-[(2S)-2-hydroxy-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]pyridine-4-carboxamide,
2-(Cyclobutylamino)-N-[(2s)-3-(3,4-Dihydroisoquinolin-2(1h)-Yl)-2-Hydroxypropyl]pyridine-4-Carboxamide,
GTPL8954,
SCHEMBL16220740,
BDBM178085,
EX-A1117,
KS-00000TT7,
MFCD30187524,
s8111,
AKOS030526610,
EPZ015866(GSK591),
ZINC521836465,
CS-5643,
SB19131,
NCGC00483168-01,
GSK591, >=97% (HPLC),
gsk591-epz015866-gsk3203591,
HY-100235,
A14374,
US9675614, 188,
GSK591 (EPZ015866,GSK3203591),
GSK591; EPZ015866; GSK3203591,
(S)-2-(Cyclobutylamino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)isonicotinamide,
4-Pyridinecarboxamide, 2-(cyclobutylamino)-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-,
4Z2,